IPI-940

N/A

Report date: 2024/04/11 14:25:56
NME

Base Information

Drug NameIPI-940
Drug Alias NameIPI-940
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnandamide amidohydrolase inhibitors
TargetsAnandamide amidohydrolase
Therapy Area/IndicationsPainNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInfinity Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInfinityPurdue Pharma
Active IndicationsN/A
Inactive IndicationsPainNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A